Heart care study for people starting cancer treatment
Treatments studied
Part of Cancer, Heart & circulation clinical trials.
This study follows adults who are referred to a heart (cardio-oncology) specialist before starting cancer treatment. It may help doctors better understand heart outcomes in people with cancer and improve how heart risks are managed early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be an adult (not a child) with a new cancer treatment planned soon
- Have been referred to a heart specialist for people with cancer before starting treatment
- Be able to complete the study intake form with required information
- Be willing to sign consent to join
- Not be pregnant or breastfeeding
- Not be under legal guardianship
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how targeted cancer treatments affect the heart. If you are an adult with any type of cancer and are getting or will get chemotherapy (including targeted drugs), joining this study helps doctors understand heart risks better.
This trial looks at how a special heart clinic can help cancer patients avoid or manage heart problems caused by their cancer treatment. It aims to find the best ways to detect, prevent, and treat heart issues during cancer care.
This study tests a new tool that helps doctors figure out your risk for heart problems after cancer treatment. If you join, you'll get a heart risk check and possibly see a heart specialist. This could help prevent heart issues later.
This study looks at whether doctors can predict heart problems caused by certain cancer treatments. It gathers information from patients before they start treatment to build better risk-checking tools.
This study is a “registry,” meaning it collects health information from adults who are getting a new heart (cardio) evaluation related to cancer. It helps doctors better understand heart risks and care needs for different cancer types and treatments.
This study watches heart health in people starting immunotherapy (a cancer treatment that boosts the immune system) by checking blood samples for heart-related markers. It aims to find early signs of heart problems so they can be managed sooner.
Hear when a new Cardiovascular Prognosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.